AMIA is pleased to invite submissions for the 2014 Summit on Translational Bioinformatics (TBI), to be held April 7-9, 2014 at the Parc 55 Hotel in San Francisco, California. The Summit will be part of the Joint Summits on Translational Informatics and will be immediately followed by the Summit on Clinical Research Informatics (CRI) at the same venue April 9-11.
Through tutorials, lectures, panels, and posters, the 2014 TBI Summit will showcase the latest advances in bioinformatics methodology, discovery, and, increasingly, in actual clinical care through applications of personalized medicine. As in previous years, TBI and CRI will have joint programming on Wednesday, April 9. There will be an invigorated effort to integrate the CRI and TBI aspects for the Joint Summits this year and a special call for submissions that have relevance to both CRI and TBI communities.
With an emphasis on cutting edge and late breaking developments, we anticipate that the TBI Summit will continue to be the premier venue for showcasing the latest bioinformatics research at the dynamic interface of biomedical research and patient care. We look forward to your submissions and to a rich program of cutting-edge, innovative approaches in the field of Translational Bioinformatics.
Submission Deadline: October 10, 2013, 11:59 p.m. EDT
All submissions must be made through the submission site external link.
- Student Papers – New!
- Pre-Meeting Tutorials
- Abstract Submissions (Podium or Poster) – New Format!
The objectives of the AMIA 2014 Summit on Translational Bioinformatics are to:
- Present the latest bioinformatics methods and discoveries applied to biologic data, with special focus on human application
- Demonstrate how bioinformatics can enhance personalized medicine, clinical research, and public health
- Identify the current challenges of translational bioinformatics, articulate opportunities, and to define the future directions
- Identify areas of interaction among computational biology, genomics and epigenomics, statistical genetics, electronic health records, drug discovery, health information exchanges, and public health
- Improve understanding of the context in which translational bioinformatics initiatives are developed, deployed and assessed
- Share research-related issues among the nationwide initiatives on translational research informatics
- Biomedical and health informatics researchers and faculty
- Bioinformaticians, statistical geneticists, molecular biologists, and physician-scientists with interest in omic data
- Clinical and Translational Science Award (CTSA) researchers
- Computer scientists and system developers
- Computational biologists with interests in human disease, drug discovery, drug repurposing, and drug response
- Genome science ethicists, lawyers, and policy experts
- Government officials and policy makers
- Health information and knowledge management professionals
- HIT industry professionals and consultants
- Industry representatives related to bioinformatics and genomics
- Physicians, nurses, dentists, pharmacists, and other clinicians
- Public health informaticians/practitioners, patient advocates, consumer advocates,and disease management specialists
- Standards developers, with particular emphasis on EHR data repurposing or integration of omic data into EHRs